External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience CMSC 2024
Roche and Genentech at

CMSC 2024

May 29 - June 01
Nashville, USA
cmsc.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
08:20 AM
Duration 20mins Music City Center Davidson Ballroom B
Ocrelizumab Dose Selection for Treatment of Paediatric Relapsing-Remitting Multiple Sclerosis: Pharmacokinetic, Safety and Efficacy Results from OPERETTA 1
T Schreiner
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:20 AM
Duration 20mins Music City Center Davidson Ballroom B
Pregnancy and Infant Outcomes in Females Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of over 3,000 Pregnancies to Date
R Bove
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 20mins Music City Center Davidson Ballroom B
Watch Pregnancy and Infant Outcomes in Females Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of over 3,000 Pregnancies to Date
R Bove
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:40 AM
Duration 20mins Music City Center Davidson Ballroom B
Ocrelizumab Administered Subcutaneously: Results from the Clinical Development Program
S D Newsome
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:00 PM
Duration 24hrs Nashville, USA
One-Year Analysis of Ocrelizumab Treatment in Black/African American and Hispanic/Latino People With Relapsing Multiple Sclerosis From the CHIMES Trial
Lilyana Amezcua, Nancy L. Monson, Mitzi J. Williams, Timothy Vartanian, Anthony T. Reder, Krupa Pandey, Kottil Rammohan, Barry Hendin, Gregory F. Wu, Rikisha Parekh, Jinglan Pei, Ibraheem Abioye, Juan Acosta, Evanthia Bernitsas
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.